
    
      This trial is a prospective, randomized, open-label, active controlled study designed to
      investigate effects of nebivolol and carvedilol on diastolic function of the left ventricle
      (LV) in the elderly HF patients with preserved EF.

      Patients will be included in the study if they had LVEF â‰¥ 40%, NYHA functional class I, II or
      III, and clinical stability without hospital admission for HF in the preceding 3 months.
    
  